News GSK files shingles vaccine in EU Shingrix has billion dollar sales potential, according to analysts.
News Single vaccine against Zika and Dengue to be developed Companies to collaborate using 'rational vaccine design'
News First Zika vaccine trial to begin Inovio and GeneOne Life sciences to begin first-in-human trial.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.